Trial intelligence / Profile preview

Apremilast in moderate to severe lichen planus

NCT01041625Phase 2Unknown

Sponsor
Virginia Clinical Research
Start
Feb 2010
Primary completion
Feb 2012
Countries
1
01

Overview

A Phase 2 trial of apremilast in lichen planus (LP), sponsored by Virginia Clinical Research. Status: unknown.

02

Drugs

apremilast
03

Conditions

lichen planus (LP)

Beyond the preview

Go deeper on NCT01041625.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01041625.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call